Biotech

All Articles

Lykos will talk to FDA to reconsider its own decision following being rejected of MDMA therapy for trauma

.Complying with an inadequate presenting for Lykos Therapeutics' MDMA candidate for trauma at a late...

AN 2 one-halfs headcount, stops stage 3 trial after data dissatisfy

.AN2 Rehabs is actually reassessing its own business in reaction to uninspired midphase information,...

Merck pays out $700M for bispecific, spying autoimmune opening as well as opportunity to challenge Amgen in cancer

.Merck &amp Co. is actually paying out $700 million in advance to test Amgen in a blood cancer cells...

Gilead pays out J&ampJ $320M to go out licensing deal for seladelpar

.Along With Gilead Sciences almost an FDA decision for its own liver health condition drug seladelpa...

' All palms on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may find the providers setting up outdoors tents at basecamp re...

Entero giving up staff, abandoning office and also stopping R&ampD

.Mattress Liquidators has actually turned Entero Rehabs white colored as a slab. The financial insti...

Exelixis drops ADC after determining it's no match for Tivdak

.Exelixis is surrendering on its cells factor (TF)- targeting antibody-drug conjugate after ending t...

Relay loses interest in SHP2 prevention after Genentech leaves

.3 weeks after Roche's Genentech device ignored an SHP2 inhibitor pact, Relay Rehab has actually con...

Stoke's Dravet disorder med launched of partial scientific hold

.Stoke Therapeutics' Dravet disorder medication has been freed from a partial hold, clearing the met...

Fierce Biotech's Gabrielle Masson offers Tough 15 at NYSE

.Intense Biotech Partner Publisher Gabrielle Masson showed the 2024 lesson of Ferocious 15 winners o...